Can Pang
- Ophthalmology top 5%
- Retinal Diseases and Treatments 3
-
- Diabetes Management and Research 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
-
- Chronic Kidney Disease and Diabetes 2
-
- Diabetes and associated disorders 3
-
- Pancreatic function and diabetes 3
-
- Berberine and alkaloids research 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- Diabetes/Metabolism Research and Reviews (3 papers)American Journal of Physiology-Endocrinology and Metabolism (1 paper)Tetrahedron Letters (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Can Pang
14 papers receiving 408 citations
Peers
Comparison fields: 5 of 62
- Ophthalmology 87
- Endocrinology, Diabetes and Metabolism 97
- Physiology 127
- Nephrology 30
- Epidemiology 135
Countries citing papers authored by Can Pang
This map shows the geographic impact of Can Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Pang more than expected).
Fields of papers citing papers by Can Pang
This network shows the impact of papers produced by Can Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Pang. The network helps show where Can Pang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2018 | 1 | |
| 7 | 2016 | 15 | |
| 8 | 2015 | 33 | |
| 9 | 2014 | 18 | |
| 10 | 2014 | 25 | |
| 11 | 2011 | 78 | |
| 12 | 2011 | 26 | |
| 13 | 2008 | 179 | |
| 14 | 2008 | 17 |
About Can Pang
Can Pang is a scholar working on Nephrology, Ophthalmology, Endocrinology, Diabetes and Metabolism, Virology and Clinical Biochemistry, having authored 14 papers that have together received 414 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (3 papers), Diabetes Management and Research (3 papers), Diabetes and associated disorders (3 papers), Pancreatic function and diabetes (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Berberine and alkaloids research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Ophthalmology (87 citations), Endocrinology, Diabetes and Metabolism (97 citations), Physiology (127 citations), Nephrology (30 citations) and Epidemiology (135 citations). Can Pang has collaborated with scholars based in China, United States and India. Frequent co-authors include Weiping Jia, Jianping Ye, Zhan‐Guo Gao, Jun Yin, Jin Zhang, Yuqian Bao, Xuhong Hou, Kun‐san Xiang, Lili Jia and Xin Gao. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, American Journal of Physiology-Endocrinology and Metabolism, Tetrahedron Letters, Medicine and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.